99 related articles for article (PubMed ID: 12115565)
1. Expression of MUC1 splice variants in benign and malignant ovarian tumours.
Obermair A; Schmid BC; Packer LM; Leodolter S; Birner P; Ward BG; Crandon AJ; McGuckin MA; Zeillinger R
Int J Cancer; 2002 Jul; 100(2):166-71. PubMed ID: 12115565
[TBL] [Abstract][Full Text] [Related]
2. Novel MUC1 splice variants are expressed in cervical carcinoma.
Obermair A; Schmid BC; Stimpfl M; Fasching B; Preyer O; Leodolter S; Crandon AJ; Zeillinger R
Gynecol Oncol; 2001 Nov; 83(2):343-7. PubMed ID: 11606095
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
[TBL] [Abstract][Full Text] [Related]
4. MUC1 splice variants in human ocular surface tissues: possible differences between dry eye patients and normal controls.
Imbert Y; Darling DS; Jumblatt MM; Foulks GN; Couzin EG; Steele PS; Young WW
Exp Eye Res; 2006 Sep; 83(3):493-501. PubMed ID: 16631167
[TBL] [Abstract][Full Text] [Related]
5. Specific MUC1 splice variants are correlated with tumor progression in esophageal cancer.
Kahkhaie KR; Moaven O; Abbaszadegan MR; Montazer M; Gholamin M
World J Surg; 2014 Aug; 38(8):2052-7. PubMed ID: 24718884
[TBL] [Abstract][Full Text] [Related]
6. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
Zwahlen D; Tschan MP; Grob TJ; Peters UR; Fink D; Haenggi W; Altermatt HJ; Cajot JF; Tobler A; Fey MF; Aebi S
Int J Cancer; 2000 Oct; 88(1):66-70. PubMed ID: 10962441
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
Dong Y; Walsh MD; Cummings MC; Wright RG; Khoo SK; Parsons PG; McGuckin MA
J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function.
Baruch A; Hartmann M; Zrihan-Licht S; Greenstein S; Burstein M; Keydar I; Weiss M; Smorodinsky N; Wreschner DH
Int J Cancer; 1997 May; 71(5):741-9. PubMed ID: 9180140
[TBL] [Abstract][Full Text] [Related]
11. MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue.
Schut IC; Waterfall PM; Ross M; O'Sullivan C; Miller WR; Habib FK; Bayne CW
BJU Int; 2003 Feb; 91(3):278-83. PubMed ID: 12581019
[TBL] [Abstract][Full Text] [Related]
12. The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.
Baruch A; Hartmann M; Yoeli M; Adereth Y; Greenstein S; Stadler Y; Skornik Y; Zaretsky J; Smorodinsky NI; Keydar I; Wreschner DH
Cancer Res; 1999 Apr; 59(7):1552-61. PubMed ID: 10197628
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
Wang J; El-Bahrawy M
Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197
[TBL] [Abstract][Full Text] [Related]
14. Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms.
Zhang L; Vlad A; Milcarek C; Finn OJ
Cancer Immunol Immunother; 2013 Mar; 62(3):423-35. PubMed ID: 22941036
[TBL] [Abstract][Full Text] [Related]
15. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells.
Julian J; Carson DD
Biochem Biophys Res Commun; 2002 May; 293(4):1183-90. PubMed ID: 12054500
[TBL] [Abstract][Full Text] [Related]
16. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients.
Imbert Y; Foulks GN; Brennan MD; Jumblatt MM; John G; Shah HA; Newton C; Pouranfar F; Young WW
Exp Eye Res; 2009 Mar; 88(3):334-8. PubMed ID: 18619437
[TBL] [Abstract][Full Text] [Related]
17. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.
Magklara A; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Danese S; Diamandis EP
Clin Cancer Res; 2001 Apr; 7(4):806-11. PubMed ID: 11309326
[TBL] [Abstract][Full Text] [Related]
18. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.
Ricardo S; Marcos-Silva L; Pereira D; Pinto R; Almeida R; Söderberg O; Mandel U; Clausen H; Felix A; Lunet N; David L
Mol Oncol; 2015 Feb; 9(2):503-12. PubMed ID: 25454345
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.
Warrenfeltz S; Pavlik S; Datta S; Kraemer ET; Benigno B; McDonald JF
Mol Cancer; 2004 Oct; 3():27. PubMed ID: 15471544
[TBL] [Abstract][Full Text] [Related]
20. Splice variant expression of CD44 in patients with breast and ovarian cancer.
Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
